...

ECZACIBAŞI
PHARMACEUTICAL AND
INDUSTRIAL INVESTMENT CO.

FINANCIAL INFORMATION

2023/09

2022/09

Revenue

3.659.020

700.388

Gross Profit

1.636.518

236.015

Operating Profit

1.032.687

362.588

Depreciation and Amortisation

221.026

13.225

EBITDA

1.253.713

375.813

Net Income

61.962

334.169

2023/09

2022/12

Total Assets

25.224.242

23.231.857

Total Shareholder's Equity

18.563.653

18.753.668

Total Current Assets

4.541.702

2.652.966

Total Current Liabilities

2.633.652

1.310.277

Capital Expenditures

23.416

151.375

Current Ratio

1,72

2,02

Liquidity Ratio

1,24

1,42

Total Liabilities / Total Assets

0,26

0,19

Total Shareholders' Equity / Total Assets

0,74

0,81

Total Shareholders' Equity / Total Liabilities

2,79

4,19

Net Income / Total Shareholders' Equity

0,00

0,22

Net Income / Total Assets

0,00

0,18

Net Income / Revenue

0,68

2,28

Year

Date

Free Issue (%)

Right Issue (%)

Before (TRY)

Now (TRY)

1992

11.11.1992

70

70

150,000

360,000

1994

16.06.1994

115

20

360,000

846,000

1995

13.09.1995

80

-

846,000

1,522,800

1996

25.07.1996

100

-

1,522,800

3,045,600

1999

26.03.1999

300

-

3,045,600

12,182,400

2003

14.05.2003

200

-

12,182,400

36,547,400

2004

13.01.2004

400

-

36,547,200

182,736,000

2008

30.07.2008

200

-

182,736,000

548,208,000

2016

03.11.2016

25

-

137,052,000

685,260,000

Yearly Profit Distribution

2003

28.06.2004

15

13,5

15

-

2004

31.05.2005

7

6,3

7

-

2005

-

-

-

-

-

2006

-

-

-

-

-

2007

26.05.2008

15

12,75

15

-

2008

26.05.2009

11,3

9,605

11,3

2009

25.05.2010

7

5,95

7

2010

24.05.2011

7

5,95

7

2011

19.06.2012

10

8,5

10

-

2012

28.05.2013

10

8,5

10

-

2013

06.05.2014

9,6

8,16

9,6

-

2014

05.05.2015

8

6,8

8

-

2015

10.05.2016

40

34

40

-

2016

08.05.2017

50

42,5

50

-

2017

22.05.2018

20

17

20

-

2018

20.05.2019

30

25,5

30

-

2019

14.04.2020

7,3

6,205

7,3

-

2020

26.04.2021

22

18,7

22

-

2021

24.05.2022

29,2

26,28

29,2

-

2022

25.04.2023

41

36,9

41

-

...

ABOUT US

...

CORPORATE MANAGEMENT

...

ANNOUNCEMENTS AND
PRESENTATIONS

...

GENERAL ASSEMBLY